Democratic senators introduced legislation June 25 that would cap out-of-pocket costs for traditional Medicare beneficiaries.
The Medicare Cost Cap Act would install a $5,000 annual cap for Parts A and B cost-sharing — including deductibles, copays and coinsurance — beginning in 2028. Once the cap is hit, Medicare would pay 100% of covered costs for the rest of the year. The cap would change each year based on per capita Medicare spending growth.
The bill would also expand the low-income subsidy and Medicare savings programs. Beginning that same year, the bill would align the income eligibility threshold for these programs at 200% of the federal poverty level. The bill would cut a resource ceiling that may disqualify some beneficiaries. A two-way automatic eligibility recognition would also go into effect for the programs.
A June 25 Senate Finance Committee news release said, over a decade, more than 52% of beneficiaries are anticipated to surpass the $5,000 cap at least once. The bill would save enrollees $1,024 on average per year. In 2028, 3.2 million Medicare beneficiaries are projected to directly benefit from the cap, according to the release.
The bill did not outline a funding mechanism, but Medicare’s Hospital Insurance Trust Fund, which finances Part A, is expected to face a funding cliff by 2033. KFF reported Andrew Ryan, PhD, of the Providence, R.I.-based Brown University School of Public Health said, with the proposed cap, analysts estimate potential costs of at least $50 billion per year.
Earlier this year, a $2,100 annual cap on out-of-pocket prescription drug costs for Medicare beneficiaries with Part D coverage went into effect. There was a $2,000 limit set for 2025, and, like the bill proposes, that cap can be adjusted each year based on drug spending trends.
Medicare Advantage plans currently have an out-of-pocket limit of up to $9,250 for in-network services, but plans themselves can lower that cap, according to KFF.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
